ArticleCancer medicine2024

Correction to "Induction of Resistance to Neurotrophic Tropomyosin-Receptor Kinase Inhibitors by HMGCS2 via a Mevalonate Pathway".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.